646 related articles for article (PubMed ID: 15700631)
61. [Liver cirrhosis and cardiovascular system].
Ponte E; Cafagna D
Minerva Med; 1996 Jun; 87(6):299-310. PubMed ID: 8700359
[TBL] [Abstract][Full Text] [Related]
62. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
Angeli P; Volpin R; Gerunda G; Craighero R; Roner P; Merenda R; Amodio P; Sticca A; Caregaro L; Maffei-Faccioli A; Gatta A
Hepatology; 1999 Jun; 29(6):1690-7. PubMed ID: 10347109
[TBL] [Abstract][Full Text] [Related]
63. Diagnosis and treatment of hepatorenal syndrome.
Ginès P
Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):945-57. PubMed ID: 11139348
[TBL] [Abstract][Full Text] [Related]
64. Hepatorenal syndrome in children: a review.
Liu PMF; de Carvalho ST; Fradico PF; Cazumbá MLB; Campos RGB; Simões E Silva AC
Pediatr Nephrol; 2021 Aug; 36(8):2203-2215. PubMed ID: 33001296
[TBL] [Abstract][Full Text] [Related]
65. Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies.
Meltzer J; Brentjens TE
Curr Opin Anaesthesiol; 2010 Apr; 23(2):139-44. PubMed ID: 20124895
[TBL] [Abstract][Full Text] [Related]
66. Effect of dipyridamole on kidney function in cirrhosis.
Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
[TBL] [Abstract][Full Text] [Related]
67. Therapy insight: Management of hepatorenal syndrome.
Cárdenas A; Ginès P
Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):338-48. PubMed ID: 16741553
[TBL] [Abstract][Full Text] [Related]
68. New Developments in Hepatorenal Syndrome.
Mindikoglu AL; Pappas SC
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):162-177.e1. PubMed ID: 28602971
[TBL] [Abstract][Full Text] [Related]
69. Pathogenesis of sodium and water retention in liver disease.
Niederberger M; Schrier RW
Prog Liver Dis; 1992; 10():329-47. PubMed ID: 1296235
[TBL] [Abstract][Full Text] [Related]
70. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.
Schrier RW; Arroyo V; Bernardi M; Epstein M; Henriksen JH; Rodés J
Hepatology; 1988; 8(5):1151-7. PubMed ID: 2971015
[TBL] [Abstract][Full Text] [Related]
71. [Diagnosis and therapy of hepatorenal syndrome].
Stremmel W; Strohmeyer G
Schweiz Rundsch Med Prax; 1992 Jun; 81(24):806-8. PubMed ID: 1376484
[TBL] [Abstract][Full Text] [Related]
72. [Endogenous digitalis-like factor in liver cirrhosis and cholestasis].
Behrens R; Glauck D; Kaltenborn G; Behrens B; Wache H; Schlee H; Rink C; Böhme I; Nilius R
Z Gastroenterol; 1993 Feb; 31 Suppl 2():20-3. PubMed ID: 7483706
[TBL] [Abstract][Full Text] [Related]
73. The kidney in cirrhosis with portal hypertension.
Olteanu D; Lupu D
J Med Life; 2010; 3(2):175-7. PubMed ID: 20968204
[TBL] [Abstract][Full Text] [Related]
74. Hepatorenal syndrome: emerging perspectives.
Epstein M
Semin Nephrol; 1997 Nov; 17(6):563-75. PubMed ID: 9353866
[TBL] [Abstract][Full Text] [Related]
75. Review article: Management of ascites and associated complications in patients with cirrhosis.
Kuiper JJ; de Man RA; van Buuren HR
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
[TBL] [Abstract][Full Text] [Related]
76. Mechanism of sodium retention and ascites formation in cirrhosis.
Arroyo V; Ginès P
J Hepatol; 1993; 17 Suppl 2():S24-8. PubMed ID: 8491967
[TBL] [Abstract][Full Text] [Related]
77. [Diagnostics and therapy of hepatorenal syndrome. Recommendations of of the working group on portal hypertension of the Czech Hepatology Society and the J. E. Purkinje Czech Medical Society].
Brůha R; Skupiny C; Balihar K; Drastich P; Hůlek P; Lata J; Petrtýl J; Procházka V; Spicák J; Vanásek T; Volfová M; Zdenek P; ;
Vnitr Lek; 2006 Jun; 52(6):649-50. PubMed ID: 16871772
[TBL] [Abstract][Full Text] [Related]
78. Acute kidney injury and hepatorenal syndrome in cirrhosis.
Egerod Israelsen M; Gluud LL; Krag A
J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
[TBL] [Abstract][Full Text] [Related]
79. Recent advances in hepatorenal syndrome.
Arroyo V; Torre A; Guevara M
Trop Gastroenterol; 2005; 26(1):13-20. PubMed ID: 15974232
[TBL] [Abstract][Full Text] [Related]
80. Management of ascites in cirrhosis.
Sandhu BS; Sanyal AJ
Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
